Comparison of two lansoprazole–antibiotic combinations (amoxycillin or classical triple therapy) for treatment of H. pylori infection in duodenal ulcer patients

Aim: To compare the eradicating capacity of two different antibiotic–lansoprazole combinations (amoxycillin vs. standard triple therapy) with that of lansoprazole alone in Helicobacter pylori‐positive duodenal ulcer patients.

[1]  S. Miehlke,et al.  Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. , 1995, Gastroenterology.

[2]  G. Tytgat,et al.  Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection , 1995, The Lancet.

[3]  M. Lazzaroni,et al.  Efficacy of omeprazole combined with antibiotics for Helicobacter pylori eradication and duodenal ulcer recurrence. , 1995, European journal of gastroenterology & hepatology.

[4]  J. Labenz,et al.  Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success. , 1994, Scandinavian journal of gastroenterology.

[5]  G. Tytgat.  Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence , 1994, Alimentary pharmacology & therapeutics.

[6]  J. Labenz,et al.  Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori. , 1993, The American journal of gastroenterology.

[7]  H. Satoh,et al.  Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori , 1991, Antimicrobial Agents and Chemotherapy.

[8]  A. Goddard,et al.  One-week low-dose triple therapy: new standards for Helicobacter pylori treatment. , 1995, European journal of gastroenterology & hepatology.

[9]  A. Axon,et al.  The role of acid inhibition in the treatment of Helicobacter pylori infection. , 1994, Scandinavian journal of gastroenterology. Supplement.